Overview

MK-0524B Lipid Study (MK-0524B-063)

Status:
Completed

Trial end date:
2008-06-16

Target enrollment:

Participant gender:

Summary

This is a 20-week clinical trial in participants with primary hypercholesterolemia or mixed dyslipidemia to demonstrate the effect of MK-0524B compared to MK-0524A + Simvastatin on lipid values.

Phase:

Phase 3

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.

Treatments:

Simvastatin